SCHEMBL528162

SCHEMBL528162

BrCC1COCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28165354 1.00
SCHEMBL10754610 0.79
SCHEMBL78600 0.78
SCHEMBL2461280 0.78
SCHEMBL4180170 0.78
SCHEMBL7130992 0.76
Ammonia Solution, Strong SCHEMBL10573407 0.76
SCHEMBL5668345 0.75
SCHEMBL8618064 0.74
SCHEMBL10349084 0.74 CHRM2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025090284-A1 ELECTROLYTE COMPRISING SOLVENT WITH NON-FLUORINE HALOGEN SUBSTITUTE AND BATTERIES COMPRISING SAME FACTORIAL INC. (US) 2025-05-01 WO claimed
WO-2016142952-A1 PROCESS FOR PREPARATION OF VILAZODONE AND ITS NOVEL INTERMEDIATES NOSCH LABS PRIVATE LIMITED (IN) 2016-09-15 WO claimed
US-12494507-B2 Flame retardants for battery electrolytes ALBEMARLE CORPORATION (US) 2025-12-09 US disclosed
WO-2025090284-A1 ELECTROLYTE COMPRISING SOLVENT WITH NON-FLUORINE HALOGEN SUBSTITUTE AND BATTERIES COMPRISING SAME FACTORIAL INC. (US) 2025-05-01 WO disclosed
CN-117986153-A Ionizable cationic lipid compound, and preparation method and application thereof 晟迪生物医药(苏州)有限公司 2024-05-07 CN disclosed
CN-114730941-A Flame retardant for battery electrolytes 雅宝公司 2022-07-08 CN disclosed
EP-3096369-B1 ORGANIC SOLAR CELL AND METHOD FOR MANUFACTURING SAME LG CHEMICAL LTD (KR) 2020-10-14 EP disclosed
CN-105940517-B Organic solar cell and method for manufacturing same 株式会社LG化学 2018-11-09 CN disclosed
CN-103974948-B Substituted benzyl indazoles as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases 拜耳医药股份有限公司 2017-07-28 CN disclosed
US-9695175-B2 Highly selective c-Met inhibitors as anticancer agents CB THERAPEUTICS INC. (KY) 2017-07-04 US disclosed
US-9695175-B2 Highly selective c-Met inhibitors as anticancer agents CB THERAPEUTICS INC. (KY) 2017-07-04 US disclosed
EP-0822931-A1 PIPERAZINONES USEFUL AS INHIBITORS OF PLATELET AGGREGATION Takeda Chemical Industries, Ltd. (JP) 1998-02-11 EP disclosed
US-5318989-A Antitumor and -carcinogenic agents; antibiotics; aglycones of esperamycins and calichemicins and having the same mechanism of bioactivity BRISTOL-MYERS SQUIBB COMPANY (US) 1994-06-07 US disclosed
US-5198560-A Antitumor agents based on esperamicin antibiotics BRISTOL-MYERS SQUIBB COMPANY (US) 1993-03-30 US disclosed
EP-0454146-A1 Cytotoxic bicyclo[7.3.1] tridec-4-ene-2,6-diyne compounds and process for the preparation thereof Bristol-Myers Squibb Company (US) 1991-10-30 EP disclosed
EP-0257610-A2 Process and intermediates for the synthesis of the enantiomers of bicyclo(4.2.0)oct-2-en-7-one and derivatives and for the synthesis of bicyclo(4.2.0)octane derivatives SYNTEX (U.S.A.) INC. (US) 1988-03-02 EP disclosed
EP-0092517-B1 OXIME ETHERS, PROCESS FOR THEIR PREPARATION, AGENTS CONTAINING THESE COMPOUNDS AND THEIR USE CIBA-GEIGY AG (CH) 1986-03-12 EP disclosed
EP-0009419-B1 AGRICULTURAL SULFONAMIDES, AND PREPARATION AND USE THEREOF E.I. DU PONT DE NEMOURS AND COMPANY (US) 1986-01-02 EP disclosed
EP-0092517-A1 Oxime ethers, process for their preparation, agents containing these compounds and their use CIBA-GEIGY AG (CH) 1983-10-26 EP disclosed
EP-0010560-A1 Herbicidal sulfonamides, their preparation, compositions containing them and use thereof E.I. DU PONT DE NEMOURS AND COMPANY (US) 1980-05-14 EP disclosed